期刊
BIOSCIENCE REPORTS
卷 39, 期 -, 页码 -出版社
PORTLAND PRESS LTD
DOI: 10.1042/BSR20182160
关键词
-
资金
- NSFC [81322012, 81373174, 81471832, 81671882, 81770984]
- Science and Technology Foundation of Guangdong Province of China [2015B020225001]
- Natural Science Foundation of Guangdong Province [2014A030313051, 2016A030308017, 2017A030313105]
The regenerative and immunomodulatory characteristics of mesenchymal stem cells (MSCs) make them attractive in the treatment of many diseases. Although they have shown promising preclinical studies of immunomodulation and paracrine effects in inflammatory airway disorders and other lung diseases, there are still challenges that have to be overcome before MSCs can be safely, effectively, and routinely applied in the clinical setting. A good understanding of the roles and mechanisms of the MSC immunomodulatory effects will benefit the application of MSC-based clinical therapy. In this review, we summarize the promises and challenges of the preclinical and clinical trials of MSC therapies, aiming to better understand the role that MSCs play in attempt to treat inflammatory airway disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据